Larotrectinib Sulfate
規格
1223405-08-0CAS番号
185-359-2EC番号
(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acidIUPAC名
C21H24F2N6O6S化学式
526.5 g/mol分子量
Larotrectinib sulfate; 1223405-08-0; LOXO-101 sulfate; ARRY-470 sulfate; RDF76R62ID; UNII-RDF76R62ID; 1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1); 1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, sulfate (1:1); (3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE SULFATE (1:1); (3S)-N-{5-[(2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide sulfate (1:1); LOXO 101 sulfate; ARRY 470 Sulfate; RefChem:57160; (3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide monosulfate; LOXO-101 (sulfate); (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide sulfate; Larotrectinib sulfate [USAN]; (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid; (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate; MFCD29472286; Larotrectinib sulphate; Larotrectinib sulfate;LOXO101; C21H24F2N6O6S; Vitrakvi (TN); LOXO 101 sulfate;(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide Sulfate; LOXO-101(sulfate); orb1300381; SCHEMBL2239598; CHEMBL3989939; SCHEMBL29735039; EX-A1981A; PXHANKVTFWSDSG-QLOBERJESA-N; DTXSID401026485; HMS3886N19; Larotrectinib sulfate (JAN/USAN); LAROTRECTINIB SULFATE [MI]; LAROTRECTINIB SULFATE [JAN]; Larotrectinib (LOXO-101 sulfate); Larotrectinib (LOXO-101) sulfate; EBC-17141; HY-12866A; Larotrectinib (LOXO-101 sulfate)?; s7960; AKOS030526332; LAROTRECTINIB SULFATE [WHO-DD]; CCG-269890; CS-5314; AC-30671; BL161518; DA-65063; MS-29743; LAROTRECTINIB SULFATE [ORANGE BOOK]; T6880; D11138; (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-pyrrolidine-1-carboxamide;sulfuric acid; (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate別名
Larotrectinib Sulfateを含む製品
비트락비액(라로트렉티닙황산염)비트락비캡슐100밀리그램(라로트렉티닙황산염)비트락비캡슐25밀리그램(라로트렉티닙황산염)VITRAKVI 25 MG CAPSULAS DURASVITRAKVI 20 MG/ML SOLUCION ORAL, 2 frascos de 50 mlVITRAKVI 100 MG CAPSULAS DURASVITRAKVI 25 mg, géluleVITRAKVI 20 mg/mL, solution buvableVITRAKVI 100 mg, gélulesLarotrectinib - Shenzhen HaoruiLarotrectinib - ViatrisLarotrectinib Sulfate - Grace
1/2ページ
